foxo4 dri senolytic 2023 2024 The disordered p53 transactivation domain is the target of and the compound FOXO4-DRI Targeting the FOXO4-p53 axis by
Targeting the FOXO4 p53 axis by retro inverso peptide senolytic agents: a pharmacological strategy to mitigate brain aging and cognitive decline Naunyn Schmiedeberg's Archives of Pharmacology Springer Nature Link FOXO4 DRI Results: What to Expect (2026) Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect Cellular Senescence in Health, Disease, and Lens Aging FOXO4 DRI For Sale (10mg) Core Peptides
Pay in 4 interest-free payments of $6.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




